Sabra Healthcare REIT (NASDAQ:SBRA) Upgraded at Wall Street Zen

Sabra Healthcare REIT (NASDAQ:SBRA) was upgraded by equities research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report released on Sunday.

Several other brokerages have also weighed in on SBRA. Truist Financial increased their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “hold” rating in a research report on Friday, March 13th. UBS Group set a $19.00 price target on Sabra Healthcare REIT in a research report on Thursday, June 18th. Scotiabank dropped their price target on Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating for the company in a research note on Thursday, June 18th. Weiss Ratings downgraded Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a report on Thursday, June 4th. Finally, Citigroup lowered Sabra Healthcare REIT from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $24.00 to $19.00 in a research note on Monday, June 22nd. Four analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $21.30.

Sabra Healthcare REIT Price Performance

Sabra Healthcare REIT stock opened at $19.54 on Friday. Sabra Healthcare REIT has a 1 year low of $17.17 and a 1 year high of $21.28. The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72. The firm has a 50 day moving average price of $19.76 and a 200 day moving average price of $19.64. The company has a market cap of $4.93 billion, a price-to-earnings ratio of 31.02, a PEG ratio of 1.46 and a beta of 0.64.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.16. The company had revenue of $211.74 million for the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. Sabra Healthcare REIT’s revenue was up 20.9% on a year-over-year basis. During the same quarter last year, the firm posted $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Sell-side analysts predict that Sabra Healthcare REIT will post 1.5 earnings per share for the current year.

Institutional Investors Weigh In On Sabra Healthcare REIT

A number of large investors have recently modified their holdings of the stock. Principal Financial Group Inc. lifted its position in shares of Sabra Healthcare REIT by 21.6% during the fourth quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock worth $472,617,000 after purchasing an additional 4,431,897 shares in the last quarter. Bank of Montreal Can grew its holdings in Sabra Healthcare REIT by 8.2% during the 3rd quarter. Bank of Montreal Can now owns 2,787,655 shares of the real estate investment trust’s stock valued at $51,962,000 after purchasing an additional 211,686 shares in the last quarter. Legal & General Group Plc grew its holdings in Sabra Healthcare REIT by 16.5% during the 4th quarter. Legal & General Group Plc now owns 1,427,180 shares of the real estate investment trust’s stock valued at $27,031,000 after purchasing an additional 201,667 shares in the last quarter. UBS Group AG increased its stake in Sabra Healthcare REIT by 143.1% during the 4th quarter. UBS Group AG now owns 1,460,219 shares of the real estate investment trust’s stock worth $27,657,000 after buying an additional 859,584 shares during the period. Finally, Advisors Capital Management LLC increased its stake in Sabra Healthcare REIT by 3.2% during the 4th quarter. Advisors Capital Management LLC now owns 2,382,935 shares of the real estate investment trust’s stock worth $45,133,000 after buying an additional 73,281 shares during the period. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.